Germany· DE-A57-7faa03bad77f433b

Cefepim Stragen

A cefepime product containing cefepime, registered in Germany by Stragen Pharma Gmbh. The same ATC class is registered in 17 of our 19 countries.

ATC J01DE01

Checked against EMA Article 57 (European Union) on September 30, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about cefepimeAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Cefepime is registered in 17 of 19 countries.

Countries holding a registration under ATC J01DE01 (cefepime), each read from that country’s own register.

This record: Germany, from EMA Article 57 (European Union)
10 of them publish a price we can compare per daily dose

Search cefepime products by name

Cefepime · ATC J01DE01

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cefepime costs, country by country.

Normalised to the WHO defined daily dose (4 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Cefepime · price per daily dose (4 g)

USD · FX 28 Sept 2026

ES Spain$33.20

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)

Active substance: Cefepime
Manufacturer: Stragen Pharma Gmbh
Country: Germany (DE)
ATC code: J01DE01
ATC class: Cefepime
Defined daily dose: 4 g, P
Reimbursed: Not published by this register
Source register: EMA Article 57 (European Union)
Last checked: September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

189 interactions on record for cefepime.

Graded by severity as the source publishes them — 19 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check cefepime against other medicines How interaction checks work

Cefepime · interactions on record

189 records

19 moderate
170 info

Most severe, free to view

Sodium picosulfateA06AB08moderate
NeomycinA07AA01moderate
StreptomycinA07AA04moderate
KanamycinA07AA08moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cefepime in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cefepime products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Cefepim Aptapharma, Cefepim Mip
Belgium · Cefepim Fresenius Kabi, Céfépime Ldp-Laboratorios Torlan
Bulgaria · Алфацеф, Бактерипим
Cyprus · Cefepim Noridem, Cefepime Aptapharma
Czechia · Cefepim Mip, Cefepim Noridem
Denmark · Cefepim Mip
Estonia · Alphacef, Cefepime Mip
Spain · Cefepima Kabi, Cefepima Ldp-Laboratorios Torlan
Finland · Cefepim Mip Pharma
France · Cefepime Accord, Cefepime Noridem
Greece · Anticepim, Cefepime /Kabi
Croatia · Cefepim Aptapharma, Cefepime Kabi
Hungary · Cefepim Aptapharma, Cefepim Noridem
Italy · Cefepime Noridem, Cefepime Qilu
Lithuania · Cefepime Mip, Cefepime Norameda
Luxembourg · Cefepime Noridem
Latvia · Cefepime Mip, Cefepime Norameda
Malta · Cefepime Aptapharma
Netherlands · Cefepim Fresenius Kabi, Cefepim Noridem
Norway · Cefepim Mip
Poland · Cefepim Mip Pharma, Cefepime Aptapharma
Portugal · Cefepima Accord, Cefepima Basi
Romania · Cefepimă Aptapharma, Cefepimă Mip
Sweden · Cefepim Mip
Slovenia · Cefepim Aptapharma, Cefepim Kabi
Slovakia · Cefepim Mip, Cefepím Noridem

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c4f77d91-5f94-4111-b474-6a1e2fa5498b
GET /v1/drugs/c4f77d91-5f94-4111-b474-6a1e2fa5498b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Intravenous Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Cefepime",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

API reference MCP server Plans

See everything about cefepime.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console